Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)

NCT00218205 is registered in ClinicalTrials.gov with Department of Veterans Affairs, New Jersey as lead sponsor.

NCT NCT00218205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00218205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Hormone Resistant Prostate Cancer (HRPC)
Lead sponsor
Department of Veterans Affairs, New Jersey
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2002
Completion date
June 30, 2006
Enrollment
28
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer